Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000206756 | SCV000261447 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000222978 | SCV000274737 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000411303 | SCV000489502 | likely benign | Lynch syndrome 5 | 2016-10-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000423522 | SCV000518264 | likely benign | not specified | 2016-09-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Color Diagnostics, |
RCV000222978 | SCV000685180 | likely benign | Hereditary cancer-predisposing syndrome | 2017-04-03 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798688 | SCV002042032 | likely benign | Breast and/or ovarian cancer | 2020-12-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000423522 | SCV002074275 | likely benign | not specified | 2022-01-15 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001355678 | SCV002774194 | likely benign | not provided | 2021-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000411303 | SCV004018858 | benign | Lynch syndrome 5 | 2023-03-27 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
All of Us Research Program, |
RCV003997650 | SCV004835320 | likely benign | Lynch syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001355678 | SCV001550631 | likely benign | not provided | no assertion criteria provided | clinical testing | The MSH6 p.Leu403= variant was identified in 1 of 3786 proband chromosomes (frequency: 0.0003) from individuals or families with ovarian cancer (Pal 2012). The variant was also identified in dbSNP (ID: rs748603803) as "With Likely benign allele", ClinVar (classified as likely benign by Invitae, Ambry Genetics, Counsyl, GeneDx and Color). The variant was not identified in UMD-LSDB database. The variant was identified in control databases in 3 of 246058 chromosomes at a frequency of 0.00001 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the European population in 3 of 111550 chromosomes (freq: 0.00003); it was not observed in the African, Other, Latino, Ashkenazi Jewish, East Asian, Finnish, or South Asian populations. The p.Leu403= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |